Emergent Biosolutions EBS All other segment — Total depreciation

Other segment segments

Similar metrics at other companies

UFPIAll Other Segments — Depreciation

$1.01M+7.0%

COKEAll Other — Total depreciation and amortization expense

$5.31M-0.2%

ACDCAll Other Segments — D&A

$800K+14.3%

UNFAll Other Segments — D&A

$818K+6.9%

NFGAll Other — Depreciation, Depletion and Amortization

$0—

INNVAll other — D&A

$0-100%

Questions, answered.

What is Emergent Biosolutions's all other segment — total depreciation?

Emergent Biosolutions (EBS) reported all other segment — total depreciation of $500K in Q1 2026.

How has Emergent Biosolutions's all other segment — total depreciation changed year-over-year?

Emergent Biosolutions's all other segment — total depreciation decreased by 77.3% year-over-year, from $2.2M to $500K.

What is the long-term trend for Emergent Biosolutions's all other segment — total depreciation?

Over 2 years (2023 to 2025), Emergent Biosolutions's all other segment — total depreciation has grown at a -59.4% compound annual growth rate (CAGR), from $22.5M to $3.7M.

What does all other segment — total depreciation mean?

This metric represents the total depreciation expense allocated to the 'All other' business segment, which encompasses activities not captured within the primary commercial or core product segments. It reflects the systematic allocation of the cost of tangible assets used in these miscellaneous operations over their useful lives. Monitoring this figure helps investors understand the capital intensity and asset base maintenance requirements of the company's non-core business activities.